Joint Formulary & PAD

Beclometasone with formoterol (Fostair NEXThaler) - Asthma

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Inhaler (dry powder)
Associated Icons :
Restrictions / Comments :
Important

Fostair NEXThaler 100/6 - licensed from 18 years of age.

Not licensed for AIR.

Second line in adult asthma requiring MART. (Fobumix Easyhaler (budesonide/formoterol) is the more cost-effective option DPI)

 

Status 2

Blue
Formulations :
  • Inhaler (dry powder)
Associated Icons :
Restrictions / Comments :
Important

Fostair NEXThaler 200/6 - High dose ICS/LABA for specialist recommendation only.

Not licensed for COPD.

Prescribe by BRAND.

PAD Profile

ChemicalSubstance :
Beclometasone with formoterol (Fostair NEXThaler)
Indication :
Asthma
Group Name :
ICS LABA
Keywords :
ICS LABAs, ICS/LABAs, inhaled corticosteroids, long-acting beta agonists, respiratory, asthmatics, MART action plans, maintenance and reliever therapy
Brand Names Include :
Fostair NEXThaler
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
5
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Beclometasone with formoterol (Fostair NEXThaler) is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Asthma.

Committee Recommendations (0)

  • No records returned.